Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,332,465
+$657,492 QoQ
Shares Held
74,137
-5.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Advisory Services Network, LLC holds $159,480,021 across 17 Drug Manufacturers - General names. GILD ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,669 | $46,603,818 | |
| 2 | ABBV |
AbbVie Inc.
|
118,301 | $25,729,278 | |
| 3 | JNJ |
Johnson & Johnson
|
86,066 | $21,037,966 | |
| 4 | MRK |
Merck & Co., Inc.
|
143,304 | $17,238,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
74,137 | $10,332,465 | |
| 6 | AMGN |
Amgen Inc
|
29,101 | $10,239,178 | |
| 7 | PFE |
Pfizer Inc
|
258,469 | $7,257,803 | |
| 8 | NVS |
Novartis AG
|
38,689 | $5,909,741 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,332,465 | 74,137 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,674,973 | 78,825 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,093,564 | 81,924 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $9,795,802 | 88,354 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $9,889,080 | 88,256 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,566,301 | 71,087 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,207,885 | 62,117 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,261,843 | 62,117 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,460,565 | 74,547 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $6,110,905 | 75,434 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $6,529,069 | 87,124 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,076,272 | 78,841 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $6,848,589 | 82,543 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $7,937,690 | 92,460 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,321,310 | 102,469 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,750,675 | 93,038 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $5,603,753 | 94,260 | Shares | Sole | 2022-05-23 | |
| 2021-12-31 | $6,049,209 | 83,311 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,750,469 | 82,326 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $4,804,291 | 69,769 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,320,060 | 66,843 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $2,426,059 | 41,642 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,843,041 | 44,992 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,820,682 | 49,658 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $5,515,714 | 73,779 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||